Traditionally, we trust doctors with confidential information about our health in the knowledge that it’s in our own interests. Similarly, few patients object to the idea that such information may be used in some form for medical research. But what happens when this process is subject to scrutiny?
How explicit does our consent have to be? Since the introduction of the Data Protection Act 1998 medical researchers have raised concerns over the increasing barriers they face to accessing patient data.
These concerns have heightened amongst some researchers since the passing of the Human Tissue Act 2004 introduced in the wake of the Alder Hey and Bristol Royal Infirmary scandals. When scientific advances are unraveling the secrets of DNA and the decoding of the human genome has opened up substantial new research opportunities.
Clinical scientists and epidemiologists argue that the requirements being placed upon them are disproportionate to the use they are making of either datasets or tissues samples and, besides, their work is in the public interest.
At the heart of the debate lie key questions over trust and consent and how these can best be resolved.
To complicate things, it is no longer just medical researchers, but also public health bureaucrats who are keen to have access to our data.
Quasi-official bodies have been charged with persuading individuals to change their behaviour and lifestyles in connection with all manner of issues such as diet, exercise, smoking and alcohol consumption.
Social Marketing – the borrowing of commercial marketing techniques in the pursuit of 'public goods' – is in vogue amongst public health officials. Empowered by advanced data collection and computing techniques, armed with the latest epidemiological research, and emboldened by a mission to change unhealthy behaviour, public health officials are keen to target their messages to specific 'market segments' in most need of advice.
Are government researchers abusing patients' trust? Can and should a distinction be made between the use of data for research and public health promotion purposes, or do the benefits of data-sharing outweigh its disadvantages?- Institute of Ideas
Ross Anderson is Professor of Security Engineering at Cambridge University. He is a co-founder of a vigorously-growing new discipline: the economics of information security. Many security failures can be traced to wrong incentives rather than technical errors, and the application of microeconomic theory has shed new light on many problems that were previously considered to be intractable.
The work is particularly important for understanding not just online crime but also system safety and dependability, as well as more traditional security problems of interest to the law enforcement and insurance industries.
Anderson also made seminal contributions to peer-to-peer systems; hardware tamper-resistance; emission security; copyright marking; crypto protocols; and the security of APIs. Anderson has written extensively on the failures of real-world systems, including automatic teller machines, prepayment meters and medical record systems. Anderson is a Fellow of the IET and the IMA, and wrote the standard textbook Security Engineering: A Guide to Building Dependable Distributed Systems.
Anderson chairs the Foundation for Information Policy Research, the main UK think-tank on internet and technology policy issues.
Dr. Stuart Derbyshire is a senior lecturer in the School of Psychology, University of Birmingham. Derbyshire has recently worked in the U.S. as Assistant Professor at the University of Pittsburgh Medical Center in the Department of Anesthesiology, and as Assistant Professor at the UCLA/CURE Neuroenteric Disease Program in the VA Greater Los Angeles Healthcare System.
Derbyshire has also been a Visiting Research Fellow at the University of Pittsburgh in the Departments of Anesthesiology and Critical Care Medicine. Derbyshire has published extensively in the area of medicine, particularly around the scientific understanding of pain.
Tim Kelsey is Chair of the Executive Board of Dr Foster Intelligence, the UK's leading health and social care informatics organisation. The company, a joint venture with the NHS Information Centre, is a public-private partnership committed to improving the accessibility, coverage and use of intelligent information among frontline care professionals.
Dr Foster Intelligence works with more than 80% of acute hospital trusts and 50% of PCTs and SHAs to help monitor the quality and effectiveness of patient care. In addition, it publishes a variety of interactive local health service guides to the general public. In 2007 Dr Foster Intelligence received the Innovation award at the Laing & Buisson Independent Healthcare awards. The award is in recognition of the significant contribution RTM is making to the healthcare sector.
Kelsey is also Chief Executive of Dr Foster Research, a subsidiary set up to work with non-health service partners. In 2006, Kelsey was listed one of the 50 most influential people in the NHS by the Health Service Journal and in 2008 won the award for outstanding individual at the Healthcare Investor Awards for his work on NHS Choices.
A well-respected journalist and broadcaster, Kelsey graduated in history from Cambridge and then worked as a reporter for the Independent on Sunday and Channel 4, among others, before becoming News Editor of the Sunday Times. Kelsey co-founded Dr Foster in 2000.
Jeffrey Rosen is the President and Chief Executive Officer of the National Constitution Center, the only institution in America chartered by Congress “to disseminate information about the United States Constitution on a non-partisan basis. Rosen is also a professor at The George Washington University Law School, a nonresident senior fellow at the Brookings Institution, and a contributing editor for the Atlantic.
Mark Walport was appointed as Director of the Wellcome Trust in June 2003. He heads one of the world's largest biomedical research charities, which spends some £400 million a year in pursuit of its mission to foster and promote research with the aim of improving human and animal health.
Before joining the Trust, he was Professor of Medicine and Head of the Division of Medicine at Imperial College London where he led a research team that focused on the immunology and genetics of rheumatic diseases. He was appointed a member of the Council for Science and Technology in 2004.